LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.79 | 17.25 | 2 | 1001 | 0.0020 | -0.3077 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.79 | 17.25 | 1666 | 1001 | 1.6633 | 1.1814 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.79 | 17.25 | 1521 | 1001 | 1.5185 | 1.1478 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.76 | 17.25 | 4 | 1193 | 0.0034 | -0.2127 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.76 | 17.25 | 1816 | 1193 | 1.5215 | 1.1421 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.76 | 17.25 | 1654 | 1193 | 1.3858 | 1.1096 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.73 | 17.25 | 4 | 1290 | 0.0031 | -0.2093 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.73 | 17.25 | 1945 | 1290 | 1.5075 | 1.1363 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.73 | 17.25 | 2 | 1290 | 0.0016 | -0.2926 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.73 | 17.25 | 1748 | 1290 | 1.3548 | 1.1000 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.70 | 17.25 | 10 | 1466 | 0.0068 | -0.0816 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.70 | 17.25 | 2117 | 1466 | 1.4434 | 1.1178 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.70 | 17.25 | 1918 | 1466 | 1.3077 | 1.0855 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.67 | 17.25 | 69 | 1653 | 0.0417 | 0.2344 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.67 | 17.25 | 2345 | 1653 | 1.4185 | 1.1091 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.67 | 17.25 | 2113 | 1653 | 1.2782 | 1.0760 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.64 | 17.25 | 160 | 1887 | 0.0848 | 0.3893 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.64 | 17.25 | 2654 | 1887 | 1.4061 | 1.1032 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.64 | 17.25 | 2 | 1887 | 0.0011 | -0.2725 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.64 | 17.25 | 2398 | 1887 | 1.2705 | 1.0720 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.61 | 17.25 | 295 | 2136 | 0.1381 | 0.5044 | MN20160310_N02 | H11 |